A collection of news and information related to Novartis AG published by this site and its partners.
Displaying items 1-12 of 113 » View latimes.com items only1 2 3 4 5 6 7 8 9 10 Next >
Over the weekend, Hall of Fame center Kareem Abdul-Jabbar led a processional on a one-mile walk outside of the Georgia Dome in Atlanta. Abdul-Jabbar's Final Four Dome Dribble Fueled by Powerade was part of his campaign to encourage fun, healthy and...
The Indian Supreme Court ruled Monday that a Swiss drug company cannot patent a medicine used to treat a rare form of leukemia, in a decision with global implications for generic drugs. The court ruled that Glivec, the drug developed by Novartis, was...
Tags: Trade Dispute, Drugs and Medicines, India, Contracts, Leukemia
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions...
Tags: Pharmaceuticals, HIV, India, Health Treatments, Leukemia
Bob Toomajian worked for 16 years as Kaiser Permanente's drug purchasing manager for Southern California, giving him an insider's knowledge of how medications are priced before reaching consumers. When it comes to patented name-brand drugs, he told me,...
Voters in Switzerland, angered by high executive pay, backed a plan to increase the control of shareholders over compensation of corporate leaders. Nearly 70% of voters approved the so-called "Rip-Off Initiative," according to the Swiss television...
If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys. The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of...
World NowThe Indian Supreme Court is slated Wednesday to take up a case that aid agencies warn could have sweeping effects on medicine for the global poor, the culmination of a lengthy legal battle between a Swiss drug company and a country known as a mecca for...
World NowGreek Prime Minister Antonis Samaras launched a high-gear diplomatic offensive aimed at buying his country more time to implement reforms demanded by increasingly impatient European creditors....
Genes make us who we are — in sickness and in health. We get our genetic makeup from our parents, of course, but in the future, we might be getting genes from our doctors too. Imagine your doctor promising to cure your cancer or heart disease by...
A failed anti-rejection drug got a new purpose and a new lease on commercial life Wednesday as the Food and Drug Administration approved the medication fingolimod -- to be marketed as Gilenya -- to slow the progression of disability in multiple...
Show TrackerLike sands through the hourglass, daytime soap operas are falling off the TV grid. The recent demise started in 2007 with the cancellation of “Passions” on NBC (and later on DirecTV). Two years later, CBS nixed “The Guiding Light”...
For some people, lifestyle measures are enough to keep blood pressure under control. But they're not enough for everyone. For one thing, "many patients are not willing to change their lifestyle," says Dr. Peter Rudd, professor of medicine emeritus at the...
Apr 12, 2013 |Story| Los Angeles Times
Apr 1, 2013 |Story| Los Angeles Times
Mar 31, 2013 |Story| Los Angeles Times
Mar 25, 2013 |Column| Los Angeles Times
Mar 4, 2013 |Story| Los Angeles Times
Jan 5, 2013 |Column| Los Angeles Times
Aug 22, 2012 | Los Angeles Times
Aug 22, 2012 | Los Angeles Times
Sep 13, 2012 |Story| Los Angeles Times
Sep 22, 2010 |Story| Los Angeles Times
Apr 21, 2011 | Los Angeles Times
Feb 8, 2010 |Story| Los Angeles Times